CuraGen is a Healthcare/Biotechnology company based in Branford, Connecticut. CuraGen's investors include Cooper Hill Partners and Soros Fund Management.
Company (Alive / Active)
Phone: 203-481-1104
322 East Main Street
Branford, 06405
Connecticut, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Histone deacetylase (hdac) inhibitors for the treatment of cancer | Aug 07, 2014 | Mar 28, 2017 | Patent |
| Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof | Mar 19, 2004 | Nov 29, 2011 | Patent |
| Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same | Jul 07, 2003 | Jul 28, 2009 | Patent |
| Combination therapies using hdac inhibitors | Nov 26, 2014 | Application |
Download PDF